Pfizer's Future May Hinge on Tofacitinib FDA Action in November

Published November 4, 2012

Pfizer's Future May Hinge On Tofacitinib FDA Action In November

Filed under: drug treatment news articles

We also analyzed its new drugs in the pipeline that could partially offset the lost revenue from Lipitor sales (Could Tofacitinib Save Pfizer?). Based on the financial projection, we derived a fair value of $ 28 for PFE stock price (A Post-Lipitor …
Read more on Seeking Alpha

Connecting Patients With Experimental Drugs

Filed under: drug treatment news articles

Last year, nearly 1,200 patients received treatment with experimental drugs through the compassionate-use program for conditions including hepatitis C, cancer and rare diseases like cystic fibrosis, the FDA says. That is up from about 1,000 patients in …
Read more on Wall Street Journal